UK markets close in 6 minutes
  • FTSE 100

    -52.08 (-0.73%)
  • FTSE 250

    -292.84 (-1.64%)
  • AIM

    -5.38 (-0.66%)

    -0.0077 (-0.67%)

    -0.0225 (-1.96%)

    -236.82 (-1.32%)
  • CMC Crypto 200

    -7.52 (-1.64%)
  • S&P 500

    -53.28 (-1.41%)
  • DOW

    -325.35 (-1.07%)

    +1.30 (+1.50%)

    -13.00 (-0.75%)
  • NIKKEI 225

    +128.32 (+0.48%)

    +1,008.46 (+5.90%)
  • DAX

    -167.72 (-1.32%)
  • CAC 40

    -69.24 (-1.15%), Inc. (NASDAQ:OSTK) Analysts Just Slashed This Year's Estimates

·3-min read

Market forces rained on the parade of, Inc. (NASDAQ:OSTK) shareholders today, when the analysts downgraded their forecasts for this year. Revenue and earnings per share (EPS) forecasts were both revised downwards, with the analysts seeing grey clouds on the horizon.

Following the downgrade, the consensus from seven analysts covering is for revenues of US$2.1b in 2022, implying a chunky 12% decline in sales compared to the last 12 months. Statutory earnings per share are supposed to dive 32% to US$0.64 in the same period. Before this latest update, the analysts had been forecasting revenues of US$2.4b and earnings per share (EPS) of US$1.34 in 2022. Indeed, we can see that the analysts are a lot more bearish about's prospects, administering a substantial drop in revenue estimates and slashing their EPS estimates to boot.

Check out our latest analysis for


The consensus price target fell 16% to US$62.40, with the weaker earnings outlook clearly leading analyst valuation estimates. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic analyst has a price target of US$116 per share, while the most pessimistic values it at US$35.00. As you can see the range of estimates is wide, with the lowest valuation coming in at less than half the most bullish estimate, suggesting there are some strongly diverging views on how think this business will perform. With this in mind, we wouldn't rely too heavily on the consensus price target, as it is just an average and analysts clearly have some deeply divergent views on the business.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. These estimates imply that sales are expected to slow, with a forecast annualised revenue decline of 23% by the end of 2022. This indicates a significant reduction from annual growth of 11% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 13% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - is expected to lag the wider industry.

The Bottom Line

The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for Regrettably, they also downgraded their revenue estimates, and the latest forecasts imply the business will grow sales slower than the wider market. Given the scope of the downgrades, it would not be a surprise to see the market become more wary of the business.

After a downgrade like this, it's pretty clear that previous forecasts were too optimistic. What's more, we've spotted several possible issues with's business, like its declining profit margins. Learn more, and discover the 2 other risks we've identified, for free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here